How Old Are Your Patients Really?: Applying biomarkers of aging to individualize life transforming treatment programs
Dr. Raffaele received his B.A. in philosophy from Princeton University and his MD from Hahnemann University Medical School in 1989. Dr. Raffaele completed his residency at the New York Hospital/Cornell University Medical Center and was formerly a clinical assistant professor of medicine at Dartmouth Medical School while in practice at the Hitchcock Clinic. Dr. Raffaele is a member of the American College of Physicians, board certified in internal medicine, and a diplomat for the American Board of Anti-Aging Medicine. In 1995, Dr. Raffaele began researching and developing a scientifically-based treatment program and co-founded PhysioAge Medical Group. Since 1997, Dr. Raffaele has been exclusively focused on anti-aging medicine and bioidentical hormone replacement therapy.
- Discuss the concept of a practical biomarker of physiological aging in the context of the National Institute on Aging’s claim that there are as of yet no validated biomarkers of aging.
- Identify five biomarkers of aging which, when combined, result in an informative overall picture of a patient’s aging process.
- Describe the blood, imaging, and other testing modalities needed to fully assess a patient for hormone replacement therapy and guide the hormone choices/routes of delivery
- Utilize the concept of objectively measured physiological (as opposed to chronological) age in making treatment decisions about for whom and what type of hormone replacement therapy is appropriate